SOLUMEDROL 500 mg, powder for solution for injection bottle
Active ingredients: Methylprednisolone, Methylprednisolone hemisuccinate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injectionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SOLUMEDROL 500 mg, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 500 mg
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Aug 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60626197CIP73022239CIP133400930222393Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTHYLPREDNISOLONEpoudre | 500,00 mg · un flacon de poudre | FT |
| MÉTHYLPREDNISOLONE (HÉMISUCCINATE DE)poudre | 633,65 mg · un flacon de poudre | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.